Wednesday, June 7, 2017
- 1:15pm-2:45pm
-
Pattern of MRI findings in ephedronic encephalopathy
Neuroimaging (Non-PD) · Exhibit Hall C
- 1:15pm-2:45pm
-
PBB3 Imaging in Parkinsonian disorders: evidence for binding to abnormally aggregated proteins in addition to tau proteins
Neuroimaging (Non-PD) · Exhibit Hall C
- 1:15pm-2:45pm
-
Perceptions of Fluctuation Treatment in Parkinson’s Disease Impact Suicidality
Parkinson's Disease: Psychiatric Manifestations · Exhibit Hall C
- 1:15pm-2:45pm
-
Physical and cognitive stimulation through environmental enrichment prevents early molecular pathology in a Parkinson´s disease model
Parkinson's Disease: Genetics · Exhibit Hall C
- 1:15pm-2:45pm
-
Piper betle L. Attenuates 6-OHDA Induced Apoptosis in SH-SY5Y Cells and Neuronal Injury in Caenorhabditis elegans Parkinson’s Model
Neuropharmacology · Exhibit Hall C
- 1:15pm-2:45pm
-
Piperine potentiate the neuroprotective effect of quercetin against MPTP induced neurotoxicity in rats
Neuropharmacology · Exhibit Hall C
- 1:15pm-2:45pm
-
Potential preclinical gait and balance markers for developing Fragile X-Associated Tremor/Ataxia Syndrome (FXTAS)
Ataxia · Exhibit Hall C
- 1:15pm-2:45pm
-
Predict Cognitive Decline with Clinical Markers in Parkinson’s Disease
Parkinson's Disease: Cognition · Exhibit Hall C
- 1:15pm-2:45pm
-
Predict cognitive decline with non-clinical markers in Parkinson’s disease
Parkinson's Disease: Cognition · Exhibit Hall C
- 1:15pm-2:45pm
-
Prediction of cognitive progression in Parkinson’s disease using three cognitive screening measures
Parkinson's Disease: Cognition · Exhibit Hall C
- «Previous Page
- 1
- …
- 24
- 25
- 26
- 27
- 28
- …
- 38
- Next Page»